ArticleCancer immunology, immunotherapy : CII2023

Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2.

Zhaojun Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.